The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20201387: Arches Holdings Inc.; Ancelux Topco S.C.A.
20201392: Capital Partners Private Equity Income Fund III, L.P.; YC Holdings, Inc.
20201394: General Atlantic Partners AIV-1 B, L.P.; RAWK Holdings LLC
20201396: Senator Global Opportunity Master Fund L.P.; CoreLogic, Inc.
20201402: BidCo 100 Limited; OneWeb Global Limited
20201407: DiamondPeak Holdings Corp.; Stephen S. Burns
20201409: The Founders Fund II, LP; Palantir Technologies Inc.
20201410: The Founders Fund III, LP; Palantir Technologies Inc.
20201411: The Founders Fund IV, LP; Palantir Technologies Inc.
20201413: Peter Thiel; Palantir Technologies Inc.
20201415: William G. Davis; James J. Arrigo
20201418: Software Acquisition Group Inc.; John S. Hendricks and Maureen D. Hendricks
AbbVie Inc. and Allergan plc, In the Matter of
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust law. On Sept. 4, 2020, the Commission announced the final consent agreement in this matter.